LSHQuanome Technologies, Inc.
Industrials
Cost of Revenue revised down 91.9% for FY 2025
This is the 8th largest revision in LSH's history.
Cost of Revenue·FY 2025
Major restatement$1.2M▼ 91.9%
was$14.9M
Revised down in a 10-K.
Verify against SEC filingsShow
As reported$14.9M
Accepted 2025-10-140001213900-25-098720
Restated$1.2M
Accepted 2026-09-250001213900-26-103571
CostOfRevenue · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time LSH — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.